Vitiligo is a noncontagious autoimmune skin depigmenting disease. Regulatory T cells
(Tregs) play a key role in maintaining peripheral tolerance; however, Tregs' number …

Regulatory T cells (Tregs) are a subset of T cells responsible for the regulation of immune
responses, thereby maintaining immune homeostasis and providing immune tolerance to …

Aim: To investigate whether systemic inflammation is increased in vitiligo patients in a case-
control study design. Material and methods: Nonsegmental vitiligo patients who had been …

Vitiligo is a skin disorder with melanocyte destruction and an autoimmune basis. Given the
importance of cytokines in autoimmunity, we aimed to find the cytokine profile of innate and …

Vitiligo is an autoimmune disease where its current treatment strategies are lengthy in
course and do not guarantee complete cure. Tofacitinib citrate (JAK inhibitor) is a potential …

Regulatory T cells (Tregs) are involved in the suppression of activated T cells in generalized
vitiligo (GV). The study was aimed to investigate Tregs functional defects in Treg: CD8+ and …

The study was aimed to analyze expression of nuclear factor of activated T cells (NFATs),
forkhead box P3 (FOXP3), and their associated genes (sCTLA4, flCTLA4, IL10, TGFB, IL2 …

Both systemic inflammation and oxidative stress play crucial roles in the pathogenesis of
vitiligo. In recent studies, monocyte to high-density lipoprotein cholesterol ratio (MHR) …

The pathophysiology of vitiligo is complex although recent research has discovered several
markers which are linked to vitiligo and associated with disease activity. Besides providing …

This cross‐sectional multicenter study aimed to evaluate serum CXCL‐10, as an activity
marker for vitiligo, and compare it with other putative serum and tissue markers. Serum …